Skip to main content
Cardiosense Recieves FDA De Novo Classification for Novel Cardiac Technology Designed to Improve Care for Patients with Heart Failure Read the press release

Press Releases

Cardiosense Appoints Medtech Executive John Martin, MD as EVP and Chief Medical Officer

Photo of Dr John Martin

Keep reading